Skip to main content

Choloxin and Alcohol/Food Interactions

There are 2 alcohol/food/lifestyle interactions with Choloxin (dextrothyroxine sodium).

Major

Dextrothyroxine Sodium High Blood Pressure (Hypertension)

Major Potential Hazard, High plausibility

dextrothyroxine - cardiovascular disease

The use of dextrothyroxine sodium is contraindicated in euthyroid patients with one or more of the following conditions: hypertension (other than mild, labile systolic hypertension); known or suspected organic heart disease, especially coronary heart disease; a history of myocardial infarction; cardiac arrhythmias or a demonstrated propensity for arrhythmias; tachycardia; rheumatic heart disease; a history of congestive heart failure; or decompensated or borderline compensated cardiac status. Dextrothyroxine sodium may cause severe cardiotoxicity related to its thyroid hormone activity, occasionally even in patients without apparent underlying cardiac abnormalities. In a large study involving men who had had a myocardial infarction, treatment with dextrothyroxine sodium was associated with a trend toward increased mortality relative to placebo. Therapy with dextrothyroxine sodium should be considered and administered cautiously in patients with risk factors for coronary artery disease, including obesity, a history of smoking, and/or a family history of premature coronary disease.

Major

Dextrothyroxine Sodium Obesity

Major Potential Hazard, High plausibility

dextrothyroxine - cardiovascular disease

The use of dextrothyroxine sodium is contraindicated in euthyroid patients with one or more of the following conditions: hypertension (other than mild, labile systolic hypertension); known or suspected organic heart disease, especially coronary heart disease; a history of myocardial infarction; cardiac arrhythmias or a demonstrated propensity for arrhythmias; tachycardia; rheumatic heart disease; a history of congestive heart failure; or decompensated or borderline compensated cardiac status. Dextrothyroxine sodium may cause severe cardiotoxicity related to its thyroid hormone activity, occasionally even in patients without apparent underlying cardiac abnormalities. In a large study involving men who had had a myocardial infarction, treatment with dextrothyroxine sodium was associated with a trend toward increased mortality relative to placebo. Therapy with dextrothyroxine sodium should be considered and administered cautiously in patients with risk factors for coronary artery disease, including obesity, a history of smoking, and/or a family history of premature coronary disease.

Choloxin drug interactions

There are 14 drug interactions with Choloxin (dextrothyroxine sodium).

Choloxin disease interactions

There are 5 disease interactions with Choloxin (dextrothyroxine sodium) which include:


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.